(CTVA) Corteva - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US22052L1044
CTVA EPS (Earnings per Share)
CTVA Revenue
CTVA: Seeds, Herbicides, Insecticides, Fungicides, Nitrogen Stabilizers
Corteva Inc (NYSE:CTVA) is a leading player in the agriculture industry, operating through two primary segments: Seed and Crop Protection. The company leverages cutting-edge technology to develop and supply high-quality seeds and crop protection products, enabling farmers to optimize yields, reduce losses, and improve profitability. By providing innovative trait technologies, digital solutions, and a range of crop protection products, Corteva helps farmers tackle pressing challenges such as weather resistance, disease management, and weed control.
The Seed segment is a key driver of Cortevas growth, offering advanced germplasm and traits that enhance crop resilience and nutritional value. The companys digital solutions also empower farmers to make informed decisions, maximizing yield and profitability. Meanwhile, the Crop Protection segment provides a comprehensive portfolio of products, including herbicides, insecticides, and nitrogen stabilizers, to safeguard crops against pests, diseases, and weeds. With a global presence spanning the Americas, Asia Pacific, Europe, the Middle East, and Africa, Corteva is well-positioned to capitalize on the growing demand for agricultural inputs.
From a technical analysis perspective, CTVAs stock price has been trending upwards, with the short-term SMA20 (67.80) and long-term SMA200 (60.10) indicating a bullish outlook. The Average True Range (ATR) of 1.29 suggests moderate volatility, with a daily price movement of around 1.82%. Given the current price of 70.95, near the 52-week high, we can expect some consolidation or correction in the near term. However, the overall trend remains positive, with potential for further growth.
Fundamentally, Cortevas market capitalization stands at approximately $47.1 billion, with a forward P/E ratio of 24.33 indicating moderate growth expectations. The companys Return on Equity (RoE) of 4.65% suggests room for improvement in terms of profitability. Nevertheless, Cortevas diversified product portfolio, global reach, and commitment to innovation position the company for long-term success. Based on the technical and fundamental data, our forecast suggests that CTVA will continue to trend upwards, potentially reaching $75-$80 in the next 6-12 months, driven by the growing demand for agricultural inputs and the companys innovative product offerings.
Additional Sources for CTVA Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
CTVA Stock Overview
Market Cap in USD | 49,962m |
Sector | Basic Materials |
Industry | Agricultural Inputs |
GiC Sub-Industry | Fertilizers & Agricultural Chemicals |
IPO / Inception | 2019-05-24 |
CTVA Stock Ratings
Growth Rating | 82.5 |
Fundamental | 11.4 |
Dividend Rating | 57.3 |
Rel. Strength | 37.9 |
Analysts | 4.29 of 5 |
Fair Price Momentum | 79.78 USD |
Fair Price DCF | 36.95 USD |
CTVA Dividends
Dividend Yield 12m | 1.01% |
Yield on Cost 5y | 2.62% |
Annual Growth 5y | 4.88% |
Payout Consistency | 100.0% |
Payout Ratio | 24.4% |
CTVA Growth Ratios
Growth Correlation 3m | 94.3% |
Growth Correlation 12m | 85.5% |
Growth Correlation 5y | 73% |
CAGR 5y | 23.47% |
CAGR/Max DD 5y | 0.68 |
Sharpe Ratio 12m | 0.31 |
Alpha | 27.11 |
Beta | 0.780 |
Volatility | 25.97% |
Current Volume | 1927.4k |
Average Volume 20d | 3650.2k |
As of July 01, 2025, the stock is trading at USD 74.53 with a total of 1,927,350 shares traded.
Over the past week, the price has changed by +0.12%, over one month by +5.05%, over three months by +18.72% and over the past year by +41.98%.
Neither. Based on ValueRay´s Fundamental Analyses, Corteva is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 11.35 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CTVA is around 79.78 USD . This means that CTVA is currently overvalued and has a potential downside of 7.04%.
Corteva has received a consensus analysts rating of 4.29. Therefor, it is recommend to buy CTVA.
- Strong Buy: 13
- Buy: 5
- Hold: 6
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, CTVA Corteva will be worth about 90.8 in July 2026. The stock is currently trading at 74.53. This means that the stock has a potential upside of +21.78%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 73.8 | -0.9% |
Analysts Target Price | 73.1 | -1.9% |
ValueRay Target Price | 90.8 | 21.8% |